- Home
- BRSP vs EYPT Comparison
BRSP vs EYPT Comparison
Compare BRSP & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRSP
- EYPT
- Stock Information
- Founded
- BRSP 2017
- EYPT 1987
- Country
- BRSP United States
- EYPT United States
- Employees
- BRSP N/A
- EYPT N/A
- Industry
- BRSP Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- BRSP Real Estate
- EYPT Industrials
- Exchange
- BRSP Nasdaq
- EYPT Nasdaq
- Market Cap
- BRSP 665.4M
- EYPT 741.0M
- IPO Year
- BRSP 2018
- EYPT 2005
- Fundamental
- Price
- BRSP $5.55
- EYPT $11.09
- Analyst Decision
- BRSP Buy
- EYPT Strong Buy
- Analyst Count
- BRSP 4
- EYPT 7
- Target Price
- BRSP $6.38
- EYPT $24.29
- AVG Volume (30 Days)
- BRSP 821.1K
- EYPT 643.4K
- Earning Date
- BRSP 07-29-2025
- EYPT 08-06-2025
- Dividend Yield
- BRSP 11.55%
- EYPT N/A
- EPS Growth
- BRSP N/A
- EYPT N/A
- EPS
- BRSP N/A
- EYPT N/A
- Revenue
- BRSP $335,107,000.00
- EYPT $51,898,000.00
- Revenue This Year
- BRSP N/A
- EYPT N/A
- Revenue Next Year
- BRSP $9.97
- EYPT N/A
- P/E Ratio
- BRSP N/A
- EYPT N/A
- Revenue Growth
- BRSP N/A
- EYPT 2.99
- 52 Week Low
- BRSP $4.16
- EYPT $3.91
- 52 Week High
- BRSP $6.45
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- BRSP 67.74
- EYPT 61.85
- Support Level
- BRSP $5.23
- EYPT $10.22
- Resistance Level
- BRSP $5.60
- EYPT $11.28
- Average True Range (ATR)
- BRSP 0.15
- EYPT 0.71
- MACD
- BRSP 0.04
- EYPT 0.04
- Stochastic Oscillator
- BRSP 92.54
- EYPT 89.89
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.